Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_assertion type Assertion NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_head.
- NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_assertion description "[Three studied angiogenic pathways (VHL/HIF, RTK/MAPK, and PI3K/Akt/mTOR) seem not to be upregulated in TCRC samples, so there appears to be no rationale for a general recommendation of antiangiogenic targeted therapeutic protocols for patients with these tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_provenance.
- NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_assertion evidence source_evidence_literature NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_provenance.
- NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_assertion SIO_000772 23296808 NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_provenance.
- NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_assertion wasDerivedFrom befree-20140225 NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_provenance.
- NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_assertion wasGeneratedBy ECO_0000203 NP550130.RAccYW4fIk-v53k_FuIo2iMLSp4_SVC-G7n9U9ZX-wpeU130_provenance.